In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Fulcrum Therapeutics Inc (NASDAQ: FULC) closed at $3.48 up 6.42% from its previous closing price of $3.27. In other words, the price has increased by $6.42 from its previous closing price. On the day, 0.65 million shares were traded. FULC stock price reached its highest trading level at $3.5 during the session, while it also had its lowest trading level at $3.26.
Ratios:
For a deeper understanding of Fulcrum Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.07 and its Current Ratio is at 22.07. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on September 13, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $17 previously.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on September 12, 2024, whereas the target price for the stock was revised from $15 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 07 ’24 when Tourangeau Greg sold 236 shares for $7.76 per share. The transaction valued at 1,831 led to the insider holds 11,571 shares of the business.
Tourangeau Greg sold 4,884 shares of FULC for $57,219 on Mar 08 ’24. The Vice President, Finance now owns 11,807 shares after completing the transaction at $11.72 per share. On Mar 04 ’24, another insider, Sapir Alex, who serves as the insider of the company, bought 43,360 shares for $11.35 each. As a result, the insider paid 492,028 and bolstered with 43,360 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FULC now has a Market Capitalization of 217154784 and an Enterprise Value of -46971320. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.66 while its Price-to-Book (P/B) ratio in mrq is 0.79. Its current Enterprise Value per Revenue stands at -0.575 whereas that against EBITDA is 1.521.
Stock Price History:
Over the past 52 weeks, FULC has reached a high of $13.70, while it has fallen to a 52-week low of $2.87. The 50-Day Moving Average of the stock is -46.71%, while the 200-Day Moving Average is calculated to be -55.07%.
Shares Statistics:
For the past three months, FULC has traded an average of 1.68M shares per day and 746940 over the past ten days. A total of 61.92M shares are outstanding, with a floating share count of 52.73M. Insiders hold about 15.49% of the company’s shares, while institutions hold 82.06% stake in the company. Shares short for FULC as of 1727654400 were 5896079 with a Short Ratio of 3.52, compared to 1724976000 on 8056232. Therefore, it implies a Short% of Shares Outstanding of 5896079 and a Short% of Float of 11.77.
